BCY LifeSciences Inc., Synsorb deal

SYB received 200,000 BCY shares under a 2000 agreement in which SYB granted BCY a license to carbohydrate compounds for cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). The payme...